ESYT3

ESYT3 (E-Syt3) is an ER-anchored membrane tethering and lipid transfer protein that forms PI(4,5)P2-dependent ER–plasma membrane contact sites, where it controls the phosphatidylserine composition of junctional nanodomains to regulate downstream ion transport and signaling. Its C2C domain targets the protein to the plasma membrane while its SMP domain transfers phosphatidylserine away from ER–PM junctions, thereby dissociating cAMP signaling complexes required for CFTR and NBCe1-B activation; ORP5 antagonizes this activity by resupplying phosphatidylserine (PMID:40425857, PMID:23791178, PMID:17360437). Beyond ion channel regulation, E-Syt3 participates in lipid droplet biogenesis through proteasome-dependent C2C cleavage that redirects truncated E-Syt3 to a primordial ER cisterna nucleating droplets in adipocytes (PMID:34693607), modulates POMC neuron energy homeostasis where its ablation enhances α-MSH production and protects against diet-induced obesity (PMID:32747560), and activates cGAS-STING innate immune signaling through direct STING interaction (PMID:39103908). Triple knockout of all E-Syt family members in mice yields viable, fertile animals under unchallenged conditions, indicating functional redundancy or context-dependent essentiality (PMID:27348751).

1. 2007 High

   Identification of E-Syt3's domain architecture established that its C2C domain is a plasma membrane targeting module and that C2A binds phospholipids in a Ca²⁺-dependent manner, providing the first molecular framework for understanding E-Syt family membrane association.

   Evidence Myc-tagged domain deletion constructs with localization imaging and in vitro Ca²⁺-dependent phospholipid binding assays

   PMID:17360437

   Open questions at the time

   • No lipid transfer activity demonstrated at this stage
   • Endogenous protein localization not assessed
   • Whether C2A Ca²⁺ binding is required for function in vivo unknown
2. 2013 High

   E-Syt3 was established as an ER-resident tethering protein that bridges ER–PM contacts via PI(4,5)P2-dependent C2 domain interactions and forms heteromeric complexes with other E-Syts, resolving how E-Syts create a distinct class of ER–PM contact sites separate from STIM1/Orai1 junctions.

   Evidence Live-cell imaging, co-immunoprecipitation, PI(4,5)P2 depletion, Ca²⁺ manipulation, and epistasis with STIM1/Orai1 knockdown

   PMID:23791178

   Open questions at the time

   • Lipid transfer function of SMP domain not yet shown
   • Physiological roles of E-Syt3-specific contacts unclear
   • Stoichiometry and structure of heteromeric complexes unresolved
3. 2014 Medium

   Double knockout of E-Syt2 and E-Syt3 revealed that combined loss impairs cell migration and oxidative stress resistance in vitro while mice remain viable, suggesting context-dependent rather than housekeeping roles for these tethers.

   Evidence Esyt2/Esyt3 double knockout MEFs with migration and stress survival assays; double KO mice phenotyping

   PMID:25486202

   Open questions at the time

   • Individual contribution of E-Syt3 versus E-Syt2 not separated
   • Mechanism linking ER–PM contacts to migration or stress resistance unknown
   • Challenged conditions (e.g., metabolic stress) not tested in vivo
4. 2015 Medium

   Discovery that E-Syt3 selectively interacts with activated FGFR1 in a conformation-dependent, phosphorylation-independent manner raised the possibility that ER–PM contacts sense receptor tyrosine kinase signaling states.

   Evidence Co-immunoprecipitation with wild-type and kinase-dead FGFR1, domain-deletion mutagenesis

   PMID:25922075

   Open questions at the time

   • Functional consequence of FGFR1–E-Syt3 interaction not determined
   • No reciprocal validation with endogenous proteins
   • Downstream signaling impact uncharacterized
5. 2016 High

   Triple E-Syt knockout mice were viable and fertile, definitively showing that E-Syts including E-Syt3 are dispensable for basic ER function and development under standard laboratory conditions, pointing toward stress- or tissue-specific roles.

   Evidence Constitutive and conditional triple KO mice with histology and synaptic protein analysis; independently replicated

   PMID:27348751 PMID:27399837

   Open questions at the time

   • Metabolic, immune, or other challenge conditions not systematically tested
   • Compensatory mechanisms by non-E-Syt tethers not explored
6. 2017 Medium

   RASSF4 was identified as an upstream regulator of E-Syt3 ER–PM tethering through ARF6-dependent control of PM PI(4,5)P2 levels, placing E-Syt3 within a defined signaling hierarchy that governs contact site formation.

   Evidence siRNA knockdown of RASSF4, PI(4,5)P2 biosensor imaging, Co-IP with ARF6, live-cell imaging of E-Syt localization

   PMID:28600435

   Open questions at the time

   • Direct physical interaction between RASSF4 and E-Syt3 not shown
   • Whether RASSF4 regulation is tissue-specific is unknown
   • Functional consequences downstream of altered E-Syt3 tethering not measured
7. 2017 Medium

   E-Syt3 knockdown enhanced HSV-1 viral release and cell-to-cell spread, establishing an unexpected role for E-Syt3 as a negative regulator of membrane fusion events during viral infection.

   Evidence siRNA knockdown of E-Syt1/E-Syt3, viral plaque assays, syncytia formation assays

   PMID:29046455

   Open questions at the time

   • E-Syt1 and E-Syt3 contributions not cleanly separated
   • Mechanism by which E-Syt3 inhibits membrane fusion unclear
   • Generalizability to other enveloped viruses untested
8. 2020 High

   Conditional ablation of E-Syt3 in hypothalamic POMC neurons demonstrated that E-Syt3 promotes diet-induced obesity by suppressing POMC processing to α-MSH through PKC/AP-1/prohormone convertase pathways, establishing the first tissue-specific in vivo function for E-Syt3.

   Evidence POMC neuron-specific conditional KO mice, metabolic phenotyping, α-MSH quantification, PKC/AP-1 activity assays, AAV overexpression

   PMID:32747560

   Open questions at the time

   • How ER–PM contact lipid composition controls PKC/AP-1 in POMC neurons not resolved
   • Whether lipid transfer activity is required for the metabolic phenotype unknown
   • Relevance to human obesity not established
9. 2021 Medium

   Proteasome-dependent cleavage of E-Syt3's C2C domain during adipogenesis redirects the truncated protein to a primordial ER cisterna that nucleates lipid droplet biogenesis, revealing a regulated post-translational mechanism that converts a PM-tethered protein into an organelle biogenesis factor.

   Evidence Confocal and live-cell imaging, electron tomography, proteasome inhibition, siRNA knockdown with lipid droplet quantification

   PMID:34693607

   Open questions at the time

   • Protease identity mediating C2C cleavage not identified
   • Whether lipid transfer activity of truncated E-Syt3 is required for droplet nucleation unknown
   • Confirmation in primary adipocytes or in vivo lacking
10. 2024 Medium

    E-Syt3 was found to directly interact with STING and activate cGAS-STING signaling to enhance type I interferon and chemokine production, linking ER–PM contact site biology to innate immune activation in lung adenocarcinoma.

    Evidence Co-immunoprecipitation, immunofluorescence, ESYT3 overexpression/knockdown, cytokine quantification, in vivo tumor models with radiotherapy

    PMID:39103908

    Open questions at the time

    • Mechanism by which E-Syt3 activates STING (lipid transfer vs. scaffolding) not determined
    • Whether this extends beyond lung adenocarcinoma untested
    • Structural basis of E-Syt3–STING interaction unknown
11. 2025 High

    E-Syt3 was definitively shown to function as a phosphatidylserine lipid transfer protein that depletes PtdSer from ER–PM junctional nanodomains, thereby dissociating cAMP signaling complexes and preventing CFTR and NBCe1-B activation; ORP5 was identified as a functional antagonist resupplying PtdSer, establishing the lipid-transfer-to-ion-transport signaling axis as the core mechanism of E-Syt3.

    Evidence In vivo E-Syt3 KO mice, PtdSer reconstitution, CFTR and NBCe1-B activity assays, domain-deletion mutants, fluid secretion measurements in salivary glands and pancreatic ducts

    PMID:40425857

    Open questions at the time

    • Crystal or cryo-EM structure of E-Syt3 SMP domain with PtdSer cargo not available
    • Whether PtdSer transfer explains POMC neuron or STING phenotypes unknown
    • Relative contribution of E-Syt3 versus other SMP-domain lipid transfer proteins in vivo unresolved

• Key open questions include the structural basis of E-Syt3's lipid transfer selectivity, the identity of the protease cleaving C2C during adipogenesis, whether PtdSer depletion at ER–PM contacts is the unifying mechanism behind E-Syt3's diverse tissue-specific phenotypes, and whether E-Syt3 mutations contribute to human metabolic or secretory disease.
• No structural model of SMP domain–lipid complex
• Protease identity for C2C cleavage unknown
• Unifying mechanism linking lipid transfer to all reported phenotypes not tested